Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs
Antigens successfully detected on Immunohistowax processed mouse tissue sections
| Antigens | Clones | Specificity | Dilution | Sources |
|---|---|---|---|---|
| *Fusion protein; °synthesised hapten carrier protein. | ||||
| Ars, arsenate; BSA, bovine serum albumin; DC, dendritic cell; h, human; IFN-γ, interferon γ; Ig, immunoglobulin; IL, interleukin; L, ligand; MHC, major histocompatibility complex; MΦ, macrophage; NK, natural killer; PMN, polymorphonuclear cell; TCR, T cell receptor; VCAM, vascular cell adhesion molecule. | ||||
| CD2 | 12–15 | Cell adhesion molecule | 10–20 μg/ml | Southern Biotechnology Associates, Inc |
| CD3 | 7D6 | T cells | 20–30 μg/ml | Coulie and colleagues14 |
| CD4 | RM4–5 | T helper cells | 20 μg/ml | Pharmingen |
| CD8 | 53–6.7 | T cells | 20 μg/ml | Pharmingen |
| CD90/Thy 1.2 | 53–2.1 | T cells | 10–20 μg/ml | Pharmingen |
| TCRαβ | H57–597 | T cells (TCR) | 20–30 μg/ml | Pharmingen |
| TCRγδ | 13D5 | T cells (TCR) | 20–30 μg/ml | Peterman and colleagues15 |
| TCR Vβ8 | F23.2 | T cells (TCR) | 20 μg/ml | ATCC |
| TCR Vβ6 | 44.22.1 | T cells (TCR) | 20 μg/ml | Payne and colleagues16 |
| B220/CD45R | RA3–6B2 | B cells | 5–10 μg/ml | Pharmingen |
| IgD | LoMD6 | B cells | 5–10 μg/ml | Lefebvre and colleagues17 |
| IgM | LoMM9 | B cells | 5–10 μg/ml | Lefebvre and colleagues17 |
| MHC-II | 14.4.4 | B cells, DC, Mφ | 5–10 μg/ml | ATCC |
| CD11c | N418 | Mainly DC | 5–10 μg/ml | Metlay and colleagues18 |
| CD11c | HL3 | Mainly DC | 5–10 μg/ml | Pharmingen |
| CD11b/Mac-1 | M1/70 | MΦ | 5–10 μg/ml | Pharmingen |
| NK | 5E6 | NK cells | 10–20 μg/ml | Pharmingen |
| Pan-NK | DX5 | NK cells | 10–20 μg/ml | Pharmingen |
| Ly-6G/GR1 | RB6–8C5 | Granulocytes | 10–20 μg/ml | Pharmingen |
| PMN antigen | 7/4 | Neutrophils | 10–20 μg/ml | Caltag |
| CD40 | 3/23 | B cells, DC, Mφ | 10–20 μg/ml | Hasbold and colleagues19 |
| Intracytoplasmic granules | 2A1 | Mature DC | 5–10 μg/ml | Inaba and colleagues20 |
| Intracytoplasmic granules | M342 | Mature DC | Undiluted supernatant | Agger and colleagues21 |
| DEC-205 | NLDC-145 | Mature DC | 20–30 μg/ml | Kraal and colleagues22 |
| CD35 | 8C12 | CR1 (Follicular DC) | 5–10 μg/ml | Pharmingen |
| CD86/B7.2 | GL1 | Activated B cells, DC, Mφ | 10–20 μg/ml | Hathcock and colleagues23 |
| CD25 | 7D4 | Activated T cells, B cells, DC | 10–20 μg/ml | Pharmingen |
| Ly-77 | GL7 | Activated T cells, B cells | 10–20 μg/ml | Pharmingen |
| CD44 | 1M7 | Activated T cells | 10–20 μg/ml | Pharmingen |
| CD69 | H1.2F3 | Activated T cells | 10–20 μg/ml | Pharmingen |
| Phosphotyrosin | 4G10 | Activated cells | 20–30μg/ml | Upstate Biotechnology Incorporation |
| OX40 | mOX40L–hIgG1* | Activated T cells | 20–30μg/ml | Cantab Pharmaceutical Research Ltd |
| VCAM-1 | M/K-2 | Adhesion molecule | 10–20 μg/ml | R&D Systems |
| Anti-Ars Ig | Ars-BSA° | Ars specific B cells | 20 μg/ml | |
| IL-2 | S4B6 | Cytokine | 20–30 μg/ml | Pharmingen |
| IL-4 | 11B11 | Cytokine | 20–30 μg/ml | Pharmingen |
| INF-γ | Db1 | Cytokine | 20–30 μg/ml | Paineau and colleagues24 |
| IL-10 | JESS-2A5 | Cytokine | 20–30 μg/ml | Pharmingen |
Latest from JCP Education
Register for free content
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>
Free archive
The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription.
Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to
all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.









